참고문헌 (48)

1. Annikov VV Narovyansky AN Sanin AV Correction of dyslipidemia with combined use of beta-sitosterol and polyprenyl phosphates in dogs with type 1 diabetes mellitus Russian Veterinary J 2019 5 12 15 10.32416/article_5d935e17e234b1.31437966 

   

2. Blanc M Hsieh WY Robertson KA Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis PLoS Biol 2011 9 e1000598 10.1371/journal.pbio.1000598 21408089 

   상세보기

3. Bogovič P Lusa L Stupica D Impact of pre-existing treatment with statins on the course and outcome of tick-borne encephalitis PLoS ONE 2018 13 e0204773 10.1371/journal.pone.0204773 30286159 

   상세보기

4. Bonnans C Levy BD Lipid mediators as agonists for the resolution of acute lung inflammation and injury Am J Respir Cell Mol Biol 2007 36 201 205 10.1165/rcmb.2006-0269TR 16990613 

   상세보기

5. Borovaya TG Didenko LV Narovlyansky AN Histological characteristics of rete ovarii in acute period of genital herpes virus infection Morphol Newsl 2015 2 15 20 10.20340/mv-mn.2015.0(2):15-20 

   

6. Chaudhuri S Symons JA Deval J Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond Antiviral Res 2018 155 76 88 10.1016/j.antiviral.2018.05.005 29758235 

   상세보기

7. Danilov LL Maltsev SD Deyeva AV Phosprenyl: a novel drug with antiviral and immune modulating activity Arch Immunol Ther Exp 1996 44 395 400 

8. Danilov LL, Deeva AV, Maltsev SD et al (2002) Remedy for the prevention and treatment of infectious diseases and the correction of pathological conditions of a living organism. RF Patent No. 2177788, 01/10/2002 

9. Einav S Glenn JS Prenylation inhibitors: a novel class of antiviral agents J Antimicrob Chemother 2003 52 883 886 10.1093/jac/dkg490 14613953 

   상세보기

10. Ershov FI Narovlyansky AN Usage of interferon inducers during viral infections Vopr Virusol 2015 60 5 10 26182650 

11. Ershov FI, Narovlyansky AN, Pronin AV et al (2017) Genital Herpes in Russia: the Scope of the Problem and Treatment Prospects. In Berhardt LV (ed) Advances in Medicine and Biology, Nova Science Publishers, Inc., New York, vol 124, chapter 6, pp 121–174 

12. Gower TL Graham BS Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro Antimicrob Agents Chemother 2001 45 1231 1237 10.1128/AAC.45.4.1231-1237.2001 11257039 

    상세보기

13. Hartley MD Imperiali B At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl-phosphates Arch Biochem Biophys 2012 517 83 97 10.1016/j.abb.2011.10.018 22093697 

    상세보기

14. Ianevski A Zusinaite E Kuivanen S Novel activities of safe-in-human broad-spectrum antiviral agents Antiviral Res 2018 154 174 182 10.1016/j.antiviral.2018.04.016 29698664 

    상세보기

15. Jones MB Rosenberg JN Betenbaugh MJ Structure and synthesis of polyisoprenoids used in N -glycosylation across the three domains of life Biochim Biophys Acta 2009 1790 485 494 10.1016/j.bbagen.2009.03.030 19348869 

    상세보기

16. Kanda T Nirei K Matsumoto N Retreatment of patients with treatment failure of direct-acting antivirals: focus on hepatitis C virus genotype 1b World J Gastroenterol 2017 23 8120 8127 10.3748/wjg.v23.i46.8120 29290649 

    상세보기

17. Kuritz T (2009) Methods and compositions for modulation of innate immunity, US Patent 0306017 

18. Legendre AM Bartges JW Effect of Polyprenyl immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis J Feline Med Surg 2009 11 624 626 10.1016/j.jfms.2008.12.002 19482534 

    상세보기

19. Legendre AM Kuritz T Galyon G Polyprenyl immunostimulant treatment of cats with presumptive non-effusive feline infectious peritonitis in a field study Front Vet Sci 2017 4 7 10.3389/fvets.2017.00007 28261584 

    상세보기

20. Legendre AM Kuritz T Heidel RE Polyprenyl immunostimulant in feline rhinotracheitis: randomized placebo-controlled experimental and field safety studies Front Vet Sci 2017 4 24 10.3389/fvets.2017.00024 28289684 

    상세보기

21. Marakasova ES Eisenhaber B Maurer-Stroh S Prenylation of viral proteins by enzymes of the host: virus-driven rationale for therapy with statins and FT/GGT1 inhibitors BioEssays 2017 39 10 1700014 10.1002/bies.201700014 

    상세보기

22. Martínez-Gutierrez M Castellanos JE Gallego-Gómez JC Statins reduce dengue virus production via decreased virion assembly Intervirology 2011 54 202 216 10.1159/000321892 21293097 

    상세보기

23. Morita CT Jin C Sarikonda G Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens Immunol Rev 2007 215 59 76 10.1111/j.1600-065X.2006.00479.x 17291279 

    상세보기

24. Naesens L Stevaert A Vanderlinden E Antiviral therapies on the horizon for influenza Curr Opin Pharmacol 2016 30 106 115 10.1016/j.coph.2016.08.003 27570127 

    상세보기

25. Narovlyansky AN Deriabin PG Sedov AM Antiviral activity of polyprenyl phosphates in an experimental infection caused by the hepatitis C virus in vitro Zh J Microbiol Epidemiol Immunobiol 2012 5 81 84 

26. Narovlyansky AN Ozherelkov SV Sanin AV Antiviral activity and possible mechanisms of action of moraprenyl phosphates in experimental infection caused by the herpes simplex virus type 1 Zh J Microbiol Epidemiol Immunobiol 2014 5 54 60 

27. Narovlyansky AN Sedov AM Pronin AV Treatment of patients with chronic recurrent herpesvirus infection of genital localization: a clinical study of Fortepren preparation Zh J Microbiol Epidemiol Immunobiol 2015 4 112 118 

28. Narovlyansky AN Ivanova AM Shevlyagina NV Efficiency of polyprenyl phosphates in experimental model of genital herpes Vopr Virusol 2015 60 9 13 26665428 

29. Narovlyansky AN Pronin AV Sanin AV ID: 85: the cytokine-regulating activity of polyprenyl phosphates: clinical studies of Fortepren R Cytokine 2015 76 80 81 10.1016/j.cyto.2015.08.112 

    상세보기

30. Narovlyansky AN Ivanova AM Shevlyagina NV Effectiveness of the use of polyprenyl phosphates in the experimental model of genital herpes Vopr Virusol 2015 60 9 13 26665428 

31. Narovlyansky AN Pronin AV Sanin AV Isoprenoids: polyprenols and plyprenyl phosphates as physiologically important metabolic regulators 2018 New York Nova Science Publishers Inc 183 

32. Ozherelkov SV Timofeev AV Novikova GP Protective effect of the new antiviral drug Phosprenyl with experimental tick-borne encephalitis Vopr Virusol 2000 45 33 37 10695042 

33. Ozherelkov SV Belousova RV Danilov LL Phosprenyl inhibits the proliferation of cattle diarrhea virus and bovine infectious rhinotracheitis virus in sensitive cell cultures Vopr Vir 2001 5 43 45 

34. Palsuledesai CC Distefano MD Protein prenylation: enzymes, therapeutics, and biotechnology applications ACS Chem Biol 2015 10 51 62 10.1021/cb500791f 25402849 

    상세보기

35. Pronin AV Ozerelkov SV Narovlyansky AN Role of cytokines in immunomodulatory effects of polyprenylphosphate: new generation of antiviral drug Russ J Immunol 2000 5 156 164 

36. Pronin AV Grigorieva EA Sanin AV Polyprenols as possible factors that determine an instructive role of the innate immunity in the acquired immune response Russ J Immunol 2002 7 135 142 12687256 

    상세보기

37. Pronin AV Danilov LL Narovlyansky AN Plant polyisoprenoids and control of cholesterol level Arch Immunol Ther Exp 2014 62 31 39 10.1007/s00005-013-0253-y 

    상세보기

38. Pronin AV Ozherelkov SV Deeva AV Polyprenyl phosphates as adjuvants polarizing the immune response towards Th1 Russian J Infect Immun 2014 2 645 10.15789/2220-7619-2012-3-645-650 

    상세보기

39. Pronin AV Narovlyansky AN Shulzhenko AE New polyprenyl phosphate based preparation Fortepren as promising cytokine regulating antiviral remedy Cytokine Growth Factor Rev 2016 30 119 126 10.1016/j.cytogfr.2016.04.001 27235090 

    상세보기

40. Sanin AV Ganshina IV Sudyina GF Phosphorylated polyprenols are a new class of compounds with anti-inflammatory and bronchodilator activity Russian J Infect Immun 2011 4 355 360 

41. Sanin AV, Narovlyansky AN, Pronin AV (2011b) Immunomodulators in agriculture: a tribute to fashion or necessity? Russian Veterinary J 1:37–40. https://cyberleninka.ru/article/n/immunomodulyatory-v-selskom-hozyaystve-dan-mode-ili-neobhodimost/viewer 

42. Sato R Sterol metabolism and SREBP activation Arch Biochem Biophys 2010 501 177 181 10.1016/j.abb.2010.06.004 20541520 

    상세보기

43. Sedov AM Narovlyansky AN Pronin AV Mechanism of antiviral action and evaluation of the effectiveness of the new drug Fortepren ® in the treatment of chronic recurrent herpes virus infection of genital localization J Microbiol Epidemiol Immunobiol 2018 5 81 87 10.36233/0372-9311-2018-5-81-87 

    상세보기

44. Sobolev SM NikolaevaTN GEA The role of lectin-substrate recognition in the immunoregulatory interaction of interleukin-2 and IgG Med Immunol 2010 12 13 20 10.15789/1563-0625-2010-1-2-13-20 

    

45. Vasil’evOzherelkovKozlov ANSVVV Antiviral and immunomodulating activity of polyprenyl phosphates in viral infections Antibiot Khimioter 2008 53 3 8 

46. Welti M Regulation of dolichol-linked glycosylation Glycoconj J 2013 30 51 56 10.1007/s10719-012-9417-y 22717794 

    상세보기

47. WHO (2007–2017) Viral hepatitis: a secret killer becomes apparent. https://www.who.int/publications/10-year-review/hepatitis/en/ 

48. Zhang Q Huang L Zhang C Synthesis and biological activity of polyprenols Fitotherapia 2015 106 184 193 10.1016/j.fitote.2015.09.008 

    상세보기